Latest News and Press Releases
Want to stay updated on the latest news?
-
BATON ROUGE, LA--(Marketwired - December 03, 2015) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
-
OncBioMune Receives Notice of Patent Allowance for Cancer Vaccine ProscaVax(TM) in China and Ukraine
BATON ROUGE, LA--(Marketwired - November 10, 2015) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the...
-
BATON ROUGE, LA--(Marketwired - October 26, 2015) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) (OncBioMune or the Company), a clinical stage biopharmaceutical company engaged in the development of...
-
BATON ROUGE, LA--(Marketwired - October 09, 2015) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) (the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel...
-
BATON ROUGE, LA--(Marketwired - October 02, 2015) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) (the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel...
-
BATON ROUGE, LA--(Marketwired - September 29, 2015) - OncBioMune Pharmaceuticals, Inc. (the "Company") (OTC PINK: OBMP) announces today that subsequent to the Company's acquisition of Quint Media,...